TerminatedNCT04823364

Evaluation of Brain Neurotransmitter Levels in Adults With ADHD, Before and After Stimulant Treatment

Interventional studyAges 18–40Israel

The study in practice

Understand this study

Listed age limits: 18 years to 40 years.

Listed locations: Kfar Saba, Israel · Rehovot, IsraelSee all locations and recruitment
Compensation: Payment and expense reimbursement have not been verified.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: July 11, 2024

Recruitment status: Terminated
Enrollment listed in the registry: 60
Sponsor: Weizmann Institute of Science
Sponsor type: Research institute
Study type: Other
Intervention type: OTHER
Study phase: Not clearly listed
Locations: Israel
Age range: From 18 Years to 40 Years
Official registry ID: NCT04823364
Official title: Show the full official title
Measuring Glutamate and GABA Brain Levels in Adults With Attention Deficit Hyperactivity Disorder (ADHD) Using Magnetic Resonance Spectroscopy (MRS)

The HopeStage team will email you.

Terminated

Kfar Saba · Rehovot

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Weizmann Institute of Science, a research institute.

Who can participate?

Listed age limits: 18 years to 40 years.

Is this study still recruiting?

The registry lists this study as terminated.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.